OBJECTIVE: The purpose of this study was to test whether treating periodontal disease (PD) in pregnancy will reduce the incidence of spontaneous preterm delivery (SPTD) at < or = 35 weeks of gestation. STUDY DESIGN: A multicenter, randomized clinical trial was performed. Subjects with PD were randomized to scaling and root planing (active) or tooth polishing (control). The primary outcome was the occurrence of SPTD at <35 weeks of gestation. RESULTS: We screened 3563 subjects for PD; the prevalence of PD was 50%. Seven hundred fifty-seven subjects were assigned randomly; 378 subjects were assigned to the active group, and 379 subjects were assigned to the placebo group. Active treatment did not reduce the risk of SPTD at <35 weeks of gestation (relative risk, 1.19; 95% confidence interval [CI], 0.62-2.28) or composite neonatal morbidity (relative risk, 1.30; 95% CI, 0.83-2.04). There was a suggestion of an increase in the risk of indicated SPTD at <35 weeks of gestation in those subjects who received active treatment (relative risk, 3.01; 95% CI, 0.95-4.24). CONCLUSION: Treating periodontal disease does not reduce the incidence of SPTD. Copyright 2010. Published by Mosby, Inc.
RCT Entities:
OBJECTIVE: The purpose of this study was to test whether treating periodontal disease (PD) in pregnancy will reduce the incidence of spontaneous preterm delivery (SPTD) at < or = 35 weeks of gestation. STUDY DESIGN: A multicenter, randomized clinical trial was performed. Subjects with PD were randomized to scaling and root planing (active) or tooth polishing (control). The primary outcome was the occurrence of SPTD at <35 weeks of gestation. RESULTS: We screened 3563 subjects for PD; the prevalence of PD was 50%. Seven hundred fifty-seven subjects were assigned randomly; 378 subjects were assigned to the active group, and 379 subjects were assigned to the placebo group. Active treatment did not reduce the risk of SPTD at <35 weeks of gestation (relative risk, 1.19; 95% confidence interval [CI], 0.62-2.28) or composite neonatal morbidity (relative risk, 1.30; 95% CI, 0.83-2.04). There was a suggestion of an increase in the risk of indicated SPTD at <35 weeks of gestation in those subjects who received active treatment (relative risk, 3.01; 95% CI, 0.95-4.24). CONCLUSION: Treating periodontal disease does not reduce the incidence of SPTD. Copyright 2010. Published by Mosby, Inc.
Authors: Patricia Weidlich; Carlos Heitor C Moreira; Tiago Fiorini; Marta L Musskopf; José M da Rocha; Maria Lucia R Oppermann; Anne M Aass; Per Gjermo; Cristiano Susin; Cassiano K Rösing; Rui V Oppermann Journal: Clin Oral Investig Date: 2013-01 Impact factor: 3.573
Authors: Harvey A Schenkein; Thomas E Koertge; Robert Sabatini; Carol N Brooks; John C Gunsolley Journal: J Periodontol Date: 2011-08-05 Impact factor: 6.993
Authors: Matthew Josiah Allen-Daniels; Myrna G Serrano; Lindsey P Pflugner; Jennifer M Fettweis; Melissa A Prestosa; Vishal N Koparde; J Paul Brooks; Jerome F Strauss; Roberto Romero; Tinnakorn Chaiworapongsa; David A Eschenbach; Gregory A Buck; Kimberly K Jefferson Journal: Am J Obstet Gynecol Date: 2015-01-28 Impact factor: 8.661
Authors: Kjersti Aagaard; Jun Ma; Kathleen M Antony; Radhika Ganu; Joseph Petrosino; James Versalovic Journal: Sci Transl Med Date: 2014-05-21 Impact factor: 17.956
Authors: Errol R Norwitz; Elizabeth A Bonney; Victoria V Snegovskikh; Michelle A Williams; Mark Phillippe; Joong Shin Park; Vikki M Abrahams Journal: Cold Spring Harb Perspect Med Date: 2015-04-27 Impact factor: 6.915
Authors: Heather A Frey; Molly J Stout; Laurel N Pearson; Methodius G Tuuli; Alison G Cahill; Jerome F Strauss; Luis M Gomez; Samuel Parry; Jenifer E Allsworth; George A Macones Journal: Am J Obstet Gynecol Date: 2016-03-12 Impact factor: 8.661